CytomX Therapeutics (CTMX) Amortizatization of Intangibles (2014 - 2026)
CytomX Therapeutics (CTMX) posted Amortizatization of Intangibles of $726000.0 for Q1 2026, up 0.97% on a QoQ basis from $719000.0 in Q4 2025, and up 59.91% year-over-year from $454000.0 in Q1 2025.
CytomX Therapeutics (CTMX) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends
CytomX Therapeutics' Amortizatization of Intangibles history runs 13 years deep, the most recent figure standing at $726000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles rose 59.91% year-over-year to $726000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 36.45% YoY) and the FY2025 annual result came in at $2.2 million, down 58.46% from the prior year.
- Amortizatization of Intangibles was $726000.0 for Q1 2026 at CytomX Therapeutics, up from $719000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.2 million in Q4 2023 and bottomed at $5000.0 in Q4 2022.
- A 5-year average of $924352.9 and a median of $726000.0 in 2026 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles jumped 44420.0% — and 2025, when it plunged 75.67%.
- CytomX Therapeutics' Amortizatization of Intangibles stood at $5000.0 in 2022, then soared by 44420.0% to $2.2 million in 2023, then plunged by 64.65% to $787000.0 in 2024, then declined by 8.64% to $719000.0 in 2025, then rose by 0.97% to $726000.0 in 2026.
- Business Quant data shows CTMX's Amortizatization of Intangibles at $726000.0 in Q1 2026, $719000.0 in Q4 2025, and $636000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | CytomX Therapeutics | 574.36 Mn | 227.66 Mn | - | 726,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 726,000.00 |
| Mar 31, 2026 | 726,000.00 |
| Dec 31, 2025 | 719,000.00 |
| Dec 31, 2025 | 719,000.00 |
| Sep 30, 2025 | 636,000.00 |
| Sep 30, 2025 | 636,000.00 |
| Jun 30, 2025 | 397,000.00 |
| Jun 30, 2025 | 397,000.00 |
| Mar 31, 2025 | 454,000.00 |
| Mar 31, 2025 | 454,000.00 |
| Dec 31, 2024 | 787,000.00 |
| Dec 31, 2024 | 787,000.00 |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Dec 31, 2023 | 2.23 Mn |